Main Topic Area
All Topic Areas
1 - 10 of 107 more >>
Articles
1 - 4 of 4
- Complementary and Alternative Medical Therapies for Diabetes
The National Center for Complementary and Alternative Medicine, part of the National Institutes of Health, defines complementary and alternative medicine as a "group of diverse medical and health care systems, practices, and products that are not presently considered to be part of conventional medicine." Complementary medicine is used with conventional therapy, whereas alternative medicine is used instead of conventional medicine. Some people with diabetes use complementary or alternative...
National Institute of Diabetes and Digestive and Kidney Diseases
- Targeted Cancer Therapies:Questions and Answers
Key Points Targeted cancer therapies use drugs that block the growth and spread of cancer by interfering with specific molecules involved in carcinogenesis (the process by which normal cells become cancer cells) and tumor growth (see Questions 1, 2, and 3). Because scientists call these molecules “molecular targets,” therapies that interfere with them are sometimes called “molecular-targeted drugs,” “molecularly targeted therapies,” or other similar names (see Question 1). The National Cancer...
- FDA Warns Consumers Not to Purchase
Green Hornet, Promoted as Herbal Version of "Ecstasy"
The Food and Drug Administration (FDA) is warning consumers not to purchase or consume a liquid product called Green Hornet. This product is promoted on the Internet, and sold in stores, as a herbal version of the illegal street drug "Ecstasy." FDA considers this product to be an unapproved new drug since it contains, among other ingredients, the undeclared active ingredients diphenhydramine and dextromethorphan, found in over-the-counter (OTC) drugs. FDA recently became aware of reports of...
U.S. Food and Drug Administration
- Biological Therapies for Cancer: Questions and Answers
Key Points Biological therapies use the body’s immune system to fight cancer or to lessen the side effects that may be caused by some cancer treatments (see Question 1). Biological response modifiers (BRMs) occur naturally in the body and can be produced in the laboratory. BRMs alter the interaction between the body’s immune defenses and cancer cells to boost, direct, or restore the body’s ability to fight the disease (see Question 3). Biological therapies include interferons,...
News
1 - 5 of 681 more >>
- Zambian Government Announces Results Of Clinical Trials Of HIV/AIDS Herbal Remedies
MedicalNewsToday - Sat, 03 Mar 2007 02:00 EST
- Studies Show Most Patients Use Complementary Alternative Medicines In Conjunction With Fertility Treatments
MedicalNewsToday - Tue, 27 Feb 2007 06:00 EST
- Gambian President Claims To Cure HIV/AIDS, Prompts Concern Among Some Public Health Workers
MedicalNewsToday - Tue, 27 Feb 2007 05:00 EST
- EU Institutions Press For Early Adoption Of Advanced Therapies Regulation
MedicalNewsToday - Tue, 27 Feb 2007 05:00 EST
- United Therapeutics Announces Pulmonary Hypertension Opinion Leaders' Guidance On Intravenous Therapies
MedicalNewsToday - Tue, 27 Feb 2007 08:00 EST
Clinical Trials
1 - 5 of 181 more >>
- Herbal Therapy in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00028977 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00014378 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00060086 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00055718 - Active, not recruiting
Drug Toxicity; childhood acute lymphoblastic leukemia
- American Ginseng in Treating Patients With Cancer-Related Fatigue
ClinicalTrials.gov Identifier: NCT00182780 - Active, not recruiting
Fatigue; unspecified adult solid tumor, protocol specific

Not Signed In -

